FOx Biosystems SA
Ouverture de faillite 13.8 FTEThe score of FOx Biosystems shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Equity -65 % Total assets -30 % Headcount (avg FTE) +106 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
FOx Biosystems's annual accounts
Filed annual accounts
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 04 Jul 2023
- Year ended 31 Dec 2021filed on 08 Jul 2022
- Year ended 31 Dec 2020filed on 08 Jul 2021
- Year ended 31 Dec 2019filed on 15 Jul 2020
FOx Biosystems's financial analysis
- Solvency47.5%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of FOx Biosystems
FOx Biosystems's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0653.744.366
- VAT number
- BE0653744366
- Peppol
- Not found on Peppol as of 08 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 03 May 2016
- Registered office
- 3590 Diepenbeek
- Size
- Small · 13.8 FTE
- Latest accounts
- 2023 · filed on 09 Jul 2024
- Activity
- Research and experimental development on biotechnology (NACE 72101)
FOx Biosystems (SA) has been based in Diepenbeek since 2016, active in: research and experimental development on biotechnology. For 2023, it reports a net loss of €2.79m and equity of €1.29m; its revenue is not published. With 13.8 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 47.5%, below the median of its sector (61.7%).
Companies similar to FOx Biosystems
Companies in the same business, of comparable size and area, outside its group.
- Aneurotech Research and experimental development on natural sciences and engineering Alken · balance sheet €2.91m
- Inhatarget Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €2.16m
- Novobiom Research and experimental development on natural sciences and engineering Liège · balance sheet €3.92m
- Quantum BioVenture Studio Research and experimental development on natural sciences and engineering Wavre · balance sheet €1.18m
- DAU Technology Research and experimental development on natural sciences and engineering Antwerp · balance sheet €3.29m
- Eurofins Professional Scientific Services Belgium Activities of head offices Mechelen · balance sheet €4.59m
- CBRA Services Public relations and communication activities Zedelgem · balance sheet €3.63m
- Protea Biopharma NV Research and experimental development on natural sciences and engineering Asse · balance sheet €1.30m
Frequently asked questions about FOx Biosystems
What is the revenue of FOx Biosystems?
FOx Biosystems files its accounts in a format where revenue is optional: it is not published for 2023.
What is the VAT number of FOx Biosystems?
In Belgium, the VAT number is the company number prefixed with BE: BE0653744366 for FOx Biosystems, if the company is VAT-registered. Its company number (CBE) is 0653.744.366.
Where is the registered office of FOx Biosystems?
According to the CBE register, the registered office of FOx Biosystems is in 3590 Diepenbeek.
What is the equity of FOx Biosystems?
At the close of the 2023 financial year, the equity of FOx Biosystems amounts to 1,290,985 €, a solvency of 47.5% of total assets.
How many people work at FOx Biosystems?
13.8 full-time equivalents on average according to the 2023 social balance sheet.
Who manages FOx Biosystems?
The register lists 13 active mandates at FOx Biosystems. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of FOx Biosystems
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →